Vitamin A deficiency reduces retinol binding protein (RBP) but not transthyretin (TTR), while inflammation reduces both RBP and TTR and increases C-reactive protein (CRP), an acute phase reactant.
INTRODUCTION
Bronchopulmonary dysplasia (BPD; neonatal chronic lung disease) is common in extremely low birth weight (ELBW; birth weight r1000 g) infants. Vitamin A deficiency occurs often in ELBW infants 1 and may predispose to BPD. 2 Multiple randomized controlled trials and a systematic review have shown that vitamin A supplementation decreases BPD or death. [3] [4] [5] In a recent multicenter trial conducted by the NICHD Neonatal Research Network, vitamin A supplementation of 5000 IU/dose given intramuscularly (i.m.) three times/week for 4 weeks decreased death rate or BPD at 36 weeks' postmenstrual age (55 vs 62%; relative risk 0.89; 95% confidence interval (CI) 0.80 to 0.99), due to a decrease in the rate of BPD. 4 Despite vitamin A supplementation, 22% of infants in the treatment group of the NICHD trial had a high retinol dose response (RDR), indicating low or absent vitamin A stores, and 25% had low serum retinol levels (<20 mcg/dl). 4 A recent randomized controlled trial comparing a higher dose (10,000 IU i.m. 3/weeks Â 4 weeks) and a ''once/week'' regimen (15,000 IU i.m. 1/weeks Â 4 weeks) to the standard regimen (5000 IU i.m. 3/weeks Â 4 weeks) observed that the higher dose regimen did not decrease biochemical evidence of vitamin A deficiency. 6 Therefore, there is evidence that biochemical evidence of vitamin A (retinol) deficiency persists in some ELBW infants despite vitamin A supplementation, and that the incidence of biochemical deficiency is not reduced by a higher dose in supplemented infants.
It is possible that BPD, periventricular leukomalacia, and other morbidities or mortality in ELBW infants are associated with an ongoing state of chronic inflammation. 7, 8 Plasma retinol concentration is a poor indicator of vitamin A status during inflammation, 9 and it is possible that biochemical evidence of vitamin A deficiency in vitamin A supplemented infants is secondary to inflammation. Retinol binding protein (RBP), in association with transthyretin (TTR), is the major carrier protein for serum retinol. Vitamin A deficiency reduces RBP but not TTR (lowers RBP/TTR ratio), 10 while inflammation reduces both RBP and TTR (maintains RBP/TTR ratio) in animal models and in children. 9,11 C-reactive protein (CRP) is an acute phase reactant that increases with infection and inflammation and is used as a screening tool for neonatal sepsis. [12] [13] [14] There is recent evidence that CRP may have a proinflammatory role in addition to being an inflammatory marker, [15] [16] [17] and high concentrations of CRP have been shown to correlate with mortality and organ failure in critically ill adults. 18 It is possible that CRP may be useful as a prognostic marker in ELBW infants. In addition, as TTR is a negative acute phase reactant, CRP may be inversely correlated with TTR and may therefore be an indicator not only of inflammation but also of vitamin A transport.
The objective in this study was to estimate RBP, TTR, and CRP in ELBW infants at 28 days to test the a priori hypotheses that TTR is a negative acute phase reactant in ELBW infants and that a higher RBP/TTR ratio or CRP concentration is associated with death/BPD at 36 weeks corrected age.
METHODS
ELBW infants who were enrolled in a trial of three vitamin A dosing regimens 6 were studied. In this trial, infants who survived to 28 study days had serum collected for retinol dose response, RBP, TTR, and CRP. These infants also had serum retinol estimated on study day 1, but samples were not collected for analysis of RBP, TTR, and CRP on study day 1 as the primary objective of the study was to evaluate the effects of vitamin A supplementation at 28 days, and it was considered desirable to minimize blood draws in the ELBW infants. The study of three vitamin A dosing regimens was a randomized partially masked trial comparing the ''Standard'' (5000 IU i.m. 3/weeks), the ''Higher dose'' (10,000 IU i.m. 3/weeks), and the ''Once/week'' (15,000 IU i.m. 1/weeks) regimens for the first four weeks. The study protocol was approved by the Institutional Review Board (IRB) and informed parental consent was obtained before randomization. The study design was similar to the NICHD Neonatal Network trial with respect to entry criteria, ages at retinol administration, and biochemical and clinical assessment methods. 4 Entry criteria were birth weight 401 to 1000 g and admitted to the NICU at the University of Alabama at Birmingham (UAB), mechanical ventilation (MV) or continuous positive airway pressure (CPAP) or supplemental oxygen at 24 h postnatal age, age Z24 h and r96 h (with randomization and administration of first dose of drug by 96 h). Exclusion criteria were any of the following: one or more major congenital anomalies, congenital nonbacterial infection with overt signs at birth, and terminal illness as evidenced by pH<6.8 for >2 h or persistent bradycardia (heart rate <100/min) associated with hypoxia for >2 h.
Serum TTR, RBP, and CRP were measured by radial immunodiffusion (The Binding Site Inc., San Diego, CA, USA), and serum retinol by HPLC on day 28 of the study (days 28 to 32 of age). The molar concentrations of TTR and RBP were calculated using molecular masses of 55,000 (tetrameric form of TTR) and 21,000, respectively, and the molar ratio was calculated. Receiver operating characteristic (ROC) curve analysis evaluated the predictive value of TTR and the RBP/TTR ratio at 28 days for death/BPD at 36 weeks (area under the curve (AUC) of ROC curve for a test no better than chance ¼ 0.5, AUC of a perfect test ¼ 1). CRP was also compared for predictive ability with a multiple logistic regression model using variables selected (race, MV-day 1, MV-day 14, MV-day 21, FiO 2 -day 28, and CRP) by best subset regression from multiple perinatal and neonatal variables (birth weight, gestational age, gender, race, CRP, RBP/TTR, MV-day 1, MV-day 7, MV-day 14, MV-day 21, MV-day28, Mean Airway Pressure (MAP)-day 1, MAP-day 7, MAP-day 21, FiO 2 -day 1, FiO 2 -day 7, FiO 2 -day 21, and FiO 2 -day 28).
Groups were compared by the Mann-Whitney Rank Sum test for continuous variables and by the w 2 test for categorical variables. Correlation was evaluated by Spearman correlation coefficients. ROC curves were developed, and AUC determined and compared using Medcalc v. 6.14 (Medcalc Software, Belgium).
RESULTS
Of the120 infants randomized in the trial from November 1999 to August 2001, 100 survived to 28 days. Adequate nonhemolyzed serum samples from day 28 were available for analysis of RBP, TTR, and CRP in 79 of these 100 infants. The mean birth weight of these infants was 709 g (SD 132 g; median 689 g; range 432 to 997 g) and the mean gestational age was 25 weeks (SD 1.6 weeks; median 25 weeks; range 22 to 31 weeks). Of the infants, 51% were male, and 65% were of non-Caucasian ethnicity. Of the 79 infants, 25 (32%) were MV on day 28, and 38 of the remaining 54 infants (48% of the 79 infants) received oxygen supplementation on day 28. Of the 79 infants, 32 (41%) died (n ¼ 6) or developed BPD (n ¼ 26) by 36 weeks' corrected age. Infants who died or developed BPD were generally of lower gestation (median; death/BPD: 25 weeks vs normal: 26 weeks, p<0.01) and smaller at birth (mean±SD; death/BPD: 676 þ 128 g vs normal: 746 þ 126 g, p<0.05), although no significant differences were noted in gender (death/BPD: 53% male vs normal: 46% male, p ¼ 0.46) and race (death/BPD: 31% white vs normal: 41% white, p ¼ 0.26). Of the 79 infants, 28 (35%) had low retinol levels (<20 mcg/dl). The 79 infants were of similar demographics as the 100 infants randomized in the trial (data not shown). Only two infants were receiving corticosteroids (which may increase serum retinol and RBP concentrations) between study days 21 and 28.
Serum TTR concentrations of ELBW infants on day 28 were 125±50 mg/l (mean±SD), about 40% lower compared to published values for adults. 19 TTR correlated with RBP (r ¼ 0.62; p<0.0001) and serum retinol on day 28 (r ¼ 0.42; p<0.001), and retinol correlated with RBP (r ¼ 0.64; p<0.0001), as expected ( Figure 1 ). There was no correlation of TTR with birth weight, gestational age, FiO 2 , or MAP at 28 days (all r<0.2, p>0.2). TTR was inversely correlated with CRP (r ¼ À0.45, p<0.0001) (Figure 1 ).
Infants with low serum retinol (<20 mcg/dl) had lower levels of TTR than infants with normal retinol level (Z20 mcg/dl). This finding indicates that vitamin A deficiency was associated with lower concentrations of its transport protein TTR. However, RBP/TTR molar ratios were not different in infants with low retinol compared with normal retinol levels, indicating that this lower concentration of TTR (and retinol in consequence) may be due to inflammation as the RBP/TTR ratio was maintained.
The AUC of TTR alone for death/BPD at 36 weeks was 0.63 (CI 0.52 to 0.74), and the AUC of the RBP/TTR ratio was 0.68 (CI 0.57 to 0.78) (p ¼ 0.59) (Figure 2) . The RBP/TTR molar ratio for infants surviving without BPD was lower than that for infants with death/BPD (median (25th to 75th centiles); 0.39 (0.33 to 0.52) vs 0.52 (0.41 to 0.70), p<0.01). CRP at 28 days was a strong independent predictor of death/BPD by 36 weeks, with an AUC for CRP alone of 0.85 (CI 0.76 to 0.92) (Figure 2 ). Infants surviving without BPD had lower CRP than infants with death/BPD (median (25th to 75th centiles); 0 (0 to 3) mg/l vs 11 (4 to 21) mg/l, p<0.001) (Figure 3) . ROC curves for RBP/TTR molar ratio and CRP concentrations on day 28 for the prediction of death/BPD by 36 weeks' corrected age. The AUC for the RBP/TTR ratio (AUC 0.68) was significantly lower than that for CRP (AUC 0.85; p<0.05). The ROC curve for TTR alone (AUC 0.63) was similar to that for RBP/TTR and is not shown. CRP>1.3 mg/l (the optimal cutoff for sensitivity and specificity) had a sensitivity of 91%, specificity of 68%, and positive/negative predictive values of 67/91%. CRP alone (AUC 0.85 (CI 0.76 to 0.92)) was comparable in predictive ability to the regression model (AUC 0.83 (CI 0.73 to 0.91); p ¼ NS), and contributed most to variance (adjusted R 2 of 0.27) in the stepwise selection of variables. In the logistic regression model shown above, if the value of CRP is considered as either above or below the optimal cutoff, the odds ratio for CRP would be 8. As CRP is also known as a marker for sepsis, we also analyzed CRP in relation to outcome after excluding infants who had been diagnosed with culture-proven sepsis from days 21 to 35 (one week before or after the measurement). Of the 79 infants, 19 were diagnosed with sepsis between days 21 and 35. When these infants were excluded, 23 infants either died or had BPD, and 37 survived without BPD. The CRP concentration in these infants (without sepsis around the time of sampling) who died or developed BPD was higher (12 (5 to The dosing regimen used (standard, high dose, or once/week) did not affect CRP, TTR, or RBP concentrations (one-way ANOVA: all p>0.2).
DISCUSSION
The main findings in this study were that a lower TTR, a higher RBP/TTR molar ratio, and a higher CRP on day 28 were associated with death/BPD at 36 weeks corrected age in ELBW infants. The inverse correlation of CRP with TTR but not with RBP is consistent with TTR (and not RBP) being a negative acute phase reactant in ELBW infants, as has been observed in older children. 11 As RBP/TTR molar ratios were not different in infants with low retinol compared with normal retinol levels, it is possible that inflammation was the underlying cause, as concomitant lowering of both TTR and RBP maintained the RBP/TTR ratio. The low TTR concentrations and maintained RBP/TTR ratio in association with higher CRP levels suggest inflammation rather than vitamin A deficiency as the cause for lower serum vitamin A levels despite supplementation in ELBW infants. The higher RBP/TTR molar ratio (due to a lower TTR) for infants with death/BPD is suggestive of an inflammatory process at the time of sampling. Infants who are therefore most at risk of BPD may perhaps be those most severely impaired in their ability to transport vitamin A, as evidenced by lower concentrations of TTR, a negative acute phase protein. In addition, CRP appears to be a strong predictor of poor outcome, even after exclusion of infants with sepsis around the time of sampling.
One limitation of this study is that sampling of infants for RBP, TTR, and CRP was performed only at a single time point of 28 study days. It is likely that a temporal profile of these analytes in association with the clinical course would be more useful for determination of prognosis. Another limitation to this and other noninterventional studies is that although associations can be observed and hypotheses generated, causal inferences cannot be made. One of the strengths of this study is that it focuses on a high-risk cohort of ELBW infants, many of whom still receive oxygen or ventilatory support at 28 days. These are the infants at high risk for mortality or morbidity such as BPD.
The RBP/TTR ratio has been shown to be useful to determine vitamin A status, with a molar ratio of r0.37 having a 82% sensitivity, 79% specificity, and 79% positive predictive value for vitamin A deficiency in adults. 20 An RBP/TTR molar ratio of r0.36 has been shown to be valid in children. 21 However, in our population of ELBW infants, the RBP/TTR ratios were not significantly different between infants with low and high retinol concentrations, suggesting that the RBP/TTR molar ratio may not be useful as an indicator of marginal vitamin A status in this population. This observation is probably due to the higher incidence of low TTR levels in this population as a consequence of inflammation, as compared to adults or older children.
The consequence of low concentrations of RBP and TTR need to be determined. It may be speculated that low concentrations of these transport proteins may impair transport of retinol into the tissues, reducing the benefits of vitamin A supplementation. Newly absorbed vitamin A (retinyl esters) are also transported by chylomicrons, providing another route for the delivery of enterally administered retinol to tissues. However, the metabolism of chylomicrons may also be impaired because lipoprotein lipase, a key enzyme in chylomicron metabolism, is also downregulated during inflammation. 22 The relative importance of chylomicrons and RBP/TTR in delivering vitamin A to tissues in infants requires investigation.
CRP, which has been conserved through vertebrate evolution, is well known as a very sensitive indicator of inflammation and tissue damage. 23 The plasma half-life of CRP is relatively constant (about 19 hours in adults), and therefore changes in plasma concentration reflect changes in production, which in turn indicates changes in the intensity of the underlying pathological process. 24 Higher CRP levels have been correlated with vascular morbidity (coronary, cerebrovascular, and peripheral vascular disease). 25 CRP levels of <1, 1 to 3, and >3 mg/l correspond to low, moderate, and high risk, respectively, for future vascular events in adults. 25 CRP has been used as a screening tool for neonatal sepsis for many years, 12-14 but literature does not exist on CRP as a prognostic factor for mortality or morbidity in premature neonates in the absence of sepsis. High levels of CRP have been shown to correlate with mortality and organ failure in critically ill adults, 18 and our study has shown that the same is true of critically ill premature infants. It is not known if CRP is just a marker for poor outcome or if the association with poor outcome is causal in nature. It is not possible to determine if elevated CRP levels preceded or followed clinical signs of inflammation in the absence of prospectively collected information on chorioamnionitis (e.g. placental pathology), exacerabations of lung disease (e.g. chest radiographs demonstrating worsening), or other obvious causes of inflammation.
CRP induces adhesion molecules (intercellular adhesion molecule (ICAM-1), vascular cell adhesion molecule (VCAM-1), and E-selectin) and monocyte chemotactic protein-1 (MCP-1) in endothelial cells in a dose-dependent manner, [15] [16] [17] and CRP may therefore have a proinflammatory role in addition to being an inflammatory marker. Higher levels of CRP (>3 mg/l) have been associated with microvascular endothelial dysfunction in the coronary circulation. 26 It is possible that higher levels of CRP in infants may similarly impair the pulmonary or the cerebral microcirculation, impairing alveolar formation and thereby resulting in BPD or predisposing to periventricular leukomalacia, respectively.
Further research is required to investigate if CRP is causally involved in the pathogenesis of BPD, and if so, determine whether CRP-targeted therapies would be effective. Even if CRP is not causally involved in the pathogenesis of BPD/death, identification of those infants at high risk of morbidity or mortality may permit the selective use of anti-inflammatory agents in these infants, with the possibility that the dose and duration of these therapies might be guided by the response in CRP. Thus, further study of CRP concentrations over the first month of life of ELBW infants is warranted.
In summary, lower concentrations of vitamin A transport proteins (TTR and RBP) and higher concentrations of CRP are associated with later mortality and morbidity (BPD) in ELBW infants. It is necessary to determine if inflammation is a confounding variable leading both to changes in TTR, RBP, and CRP as well as mortality and morbidity, or if the inflammationinduced changes in the vitamin A transport proteins and CRP contribute directly to pathophysiology in the vulnerable ELBW neonate.
